Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180.

Daito J, Katoh N, Asai J, Ueda E, Takenaka H, Ishii N, Hashimoto T, Kishimoto S.

Br J Dermatol. 2008 Sep;159(4):984-6. doi: 10.1111/j.1365-2133.2008.08753.x. Epub 2008 Jul 15. No abstract available.

PMID:
18637895
2.

Brunsting-Perry-type cicatricial pemphigoid with IgG autoantibodies to LAD-1.

García-Martín P, Fraga J, Hashimoto T, García-Diez A.

Br J Dermatol. 2014 Mar;170(3):743-5. doi: 10.1111/bjd.12677. No abstract available.

PMID:
24124894
3.

Cicatricial pemphigoid sera specifically react with the most C-terminal portion of BP180.

Lee JB, Liu Y, Hashimoto T.

J Dermatol Sci. 2003 Jun;32(1):59-64.

PMID:
12788530
4.

Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.

Bédane C, McMillan JR, Balding SD, Bernard P, Prost C, Bonnetblanc JM, Diaz LA, Eady RA, Giudice GJ.

J Invest Dermatol. 1997 Jun;108(6):901-7.

5.

Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.

Kromminga A, Sitaru C, Meyer J, Arndt R, Schmidt E, Christophers E, Bröcker EB, Zillikens D.

J Dermatol Sci. 2002 Jan;28(1):68-75.

PMID:
11916132
6.

Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.

Choi Y, Lee SE, Fukuda S, Hashimoto T, Kim SC.

J Dermatol. 2011 Feb;38(2):169-72. doi: 10.1111/j.1346-8138.2010.01072.x. Epub 2010 Nov 23.

PMID:
21269314
7.

Pure ocular mucous membrane pemphigoid reactive with both β4 integrin and the BP180 C-terminal domain.

Solano-López G, Concha-Garzón MJ, Sánchez-Pérez J, Hirako Y, Li X, Ishii N, Hashimoto T, Daudén E.

Br J Dermatol. 2015 Feb;172(2):542-4. doi: 10.1111/bjd.13290. Epub 2014 Dec 30. No abstract available.

PMID:
25059542
8.

Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain.

Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, Giudice GJ.

J Invest Dermatol. 1996 Jan;106(1):141-6.

9.

[Mucous membrane pemphigoid: IgG and IgA antibodies against the BP180 antigen].

España A, del Olmo J, Marquina M, Sitaru C.

Actas Dermosifiliogr. 2005 Jul-Aug;96(6):365-70. Spanish.

PMID:
16476255
10.

Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.

Kurashige Y, Minemura T, Nagatani T, Koga H, Hashimoto T.

Eur J Dermatol. 2013 Jan-Feb;23(1):109-10. doi: 10.1684/ejd.2012.1895. No abstract available.

PMID:
23306276
11.

A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.

Shinojima Y, Ochiai T, Kawamura A, Arakawa H, Fukuda K, Hashimoto T.

Clin Exp Dermatol. 2005 Sep;30(5):503-5.

PMID:
16045678
12.

Anti-BP180-type oral mucous membrane pemphigoid reactive to both NC16a and C-terminal domains.

Uchiyama M, Mitsuhashi Y, Tsuboi R, Ishii N, Hayakawa T, Yasukochi A, Hashimoto T.

Indian J Dermatol Venereol Leprol. 2015 Nov-Dec;81(6):637-9. doi: 10.4103/0378-6323.168330. No abstract available.

13.

Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.

Hayashi I, Shinkuma S, Shimizu S, Natsuga K, Ujiie H, Yasui C, Tsuchiya K, Nishie W, Shimizu H.

Br J Dermatol. 2012 May;166(5):1116-20. doi: 10.1111/j.1365-2133.2011.10776.x. Epub 2012 Mar 14.

PMID:
22182184
14.

A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.

Aoki N, Nakajima K, Shiga T, Koga H, Hashimoto T, Sano S.

J Dermatol. 2014 Jun;41(6):557-9. doi: 10.1111/1346-8138.12502. No abstract available.

PMID:
24909219
15.

Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.

Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M.

Clin Immunol. 2008 Sep;128(3):415-26. doi: 10.1016/j.clim.2008.04.012. Epub 2008 Jun 20.

PMID:
18571472
16.

A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5.

Kawahara Y, Amagai M, Ohata Y, Ishii K, Hasegawa Y, Hsu R, Yee C, Yancey KB, Nishikawa T.

J Am Acad Dermatol. 1998 Apr;38(4):624-7. No abstract available.

PMID:
9555805
17.

Brunsting-Perry type pemphigoid with IgG autoantibodies to laminin-332, BP230 and desmoplakins I/II.

Fukuda S, Tsuruta D, Uchiyama M, Mitsuhashi Y, Kobayashi H, Ishikawa T, Ohyama B, Ishii N, Hamada T, Dainichi T, Karashima T, Nakama T, Yasumoto S, Hashimoto T.

Br J Dermatol. 2011 Aug;165(2):433-5. doi: 10.1111/j.1365-2133.2011.10343.x. Epub 2011 Jul 11. No abstract available.

PMID:
21457206
18.

Brunsting-Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure.

TAKEICHI S, KUBO Y, ARASE S, HASHIMOTO T, ANSAI S.

Eur J Dermatol. 2009 Sep-Oct;19(5):500-3. doi: 10.1684/ejd.2009.0715. Epub 2009 Jun 5.

PMID:
19502152
19.

[Localized cicatricial bullous pemphigoid of the Brunsting-Perry type].

Kurzhals G, Maciejewski W, Agathos M, Meurer M, Mily H, Breit R.

Hautarzt. 1993 Feb;44(2):110-3. German.

PMID:
8449691
20.

Cicatrising conjunctivitis with anti-basement membrane autoantibodies in ectodermal dysplasia.

Saw VP, Dart JK, Sitaru C, Zillikens D.

Br J Ophthalmol. 2008 Oct;92(10):1403-10. doi: 10.1136/bjo.2007.130583. Review.

PMID:
18815422

Supplemental Content

Support Center